Glenmark consolidated revenue increases by 27.53% to Rs. 17,035.60 million in Q4 FY 2013-14
EBITDA grew by 46.7 per cent to Rs 3816.17 millionGlenmark Pharmaceuticals announced its full year results for the year ended…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
’Pharmaceuticals contribute 30 per cent to Ireland’s exports’
Ireland holds a formidable position on the global pharmaceutical map not only being home to nine out of ten pharma companies but…
Boehringer Ingelheim sees increase in operating income and return on net sales
Net sales of around €14.1 billion achieved
Lupin inks JV with Yoshindo
New entity YL Biologics to focus on clinical development and commercialisation of biosimilars for Japan
Suven Life secures product patents
Suven Life Sciences has received two patents, one product patent from Hong Kong (HK 1133002) and one product patent from Canada…
Piramal Enterprises, Merisant in pact
Signs exclusive sales and distribution partnership for Equal in India
Venus gets marketing nod from Venezuela for meropenem
Venus Remedies has extended its footprint in Latin America with marketing authorisation for meropenem from Venezuela
US FDA approves ofatumumab
Ofatumumab in combination with chlorambucil is effective for the treatment of previously untreated patients with chronic…